0
2022
Vertebroplasty And Kyphoplasty Market

Vertebroplasty and Kyphoplasty Market

by Product (Kyphoplasty, Vertebroplasty), by End User (Hospitals, Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A10444
Nov 2022 | Pages: 183
Tables: 111
Charts: 53
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

Vertebroplasty And Kyphoplasty Market Research, 2031

The global vertebroplasty and kyphoplasty market size was valued at $757.1 million in 2021, and is projected to reach $1,308.1 million by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Vertebroplasty and kyphoplasty are surgical procedures used to treat painful vertebral compression fractures in spine. Vertebral compression fractures result from condition such as osteoporosis, which causes bones to become weak and brittle. Vertebroplasty refers to the procedure of injecting cement into the fractured bone with the help of imaging techniques whereas kyphoplasty refers to procedure of injecting cement by creating a void or space with the help of balloon in the fractured bone. This void is further filled with cement and thus, helps in restoration of the fractured bone.

The vertebroplasty and kyphoplasty market was negatively impacted during the lockdown period owing to decrease in patient visit to the hospitals for treatment other than COVID 19. Furthermore, the pandemic situation led to unavailability of beds in hospitals for other admission purpose and hence, reduced the number of surgical procedures, which negatively impacted the sale of vertebroplasty and kyphoplasty products.

Vertebroplasty and Kyphoplasty Market

Historical overview

The market was analyzed qualitatively and quantitatively from 2018-2020. The vertebroplasty and kyphoplasty market size grew at a CAGR of around 4-6% during 2018-2021. Most of the growth during this period was derived from Asia-Pacific, owing to industrial development and investments from developed countries in Asia-Pacific and rise in awareness regarding new treatment approaches and technologies in this region. 

Market dynamics

In recent years, there is rise in adoption of minimally invasive surgeries around the globe. Vertebroplasty and kyphoplasty are few of the minimally invasive procedures adopted by healthcare providers and patients for feasible and efficient management of vertebral column fractures. These techniques offer several advantages over the traditional surgeries, such as faster recovery, less hospital stay, less invasion to the body, and improved perioperative pain management, which lead to rise in demand for vertebroplasty and kyphoplasty in the healthcare sector.

In addition, the vertebroplasty and kyphoplasty procedures are typically outpatient, and have shorter recovery periods. Small incisions can also mean better cosmetic results, and there is less potential for blood loss, infection, and postoperative pain. These benefits result in the preferences of population to minimally invasive spine procedures over the other choices, eventually contributes toward the vertebroplasty and kyphoplasty market growth.

Furthermore, there is witnessed rise in incidence of spinal disorders among the population due to various factors, such as age and accidental injuries. Increase in spinal disorders, especially osteoporosis, is a major factor that drives the market. For instance, according to National Osteoporosis Foundation, by 2025, experts predict that osteoporosis is expected to be responsible for three million fractures and result in cost of $25.3 billion for the healthcare system. This also highlights rise in number of other spinal disorders, with subsequent rise in demand for vertebroplasty and kyphoplasty. Thus, propelling the market growth during the forecast period.

Moreover, rise in accidental cases further lead to severe injuries, thus driving the vertebroplasty and kyphoplasty market. For instance, according to the report published in February 2022 by Ministry of Road Transport and Highways, Government of India, during 2020, the total recorded 3,66,138 road accidents caused loss of 1,31,714 persons lives and injured 3,48,279 persons. Thus, rise in the road accidents caused increase in incidence of spinal fracture and other spinal abnormalities, driving the vertebroplasty and kyphoplasty market.  

Furthermore, increase in geriatric population is expected to drive the growth of the vertebroplasty and kyphoplasty market. Geriatric population is more prone to diseases that lead to inability in movement, which are mainly attributed to conditions such as vertebral column fractures, degenerative discs, spinal stenosis, and deteriorated joints. Thus, vertebroplasty and kyphoplasty procedures are becoming more popular for treatment of spinal conditions in geriatric population, which notably contributes toward growth of the global market.

In addition, growth of the vertebroplasty and kyphoplasty market is expected to be driven by high potential in untapped, emerging markets, due to availability of improved healthcare infrastructure, increase in unmet healthcare needs, rise in prevalence of spinal disorders, and surge in demand for effective surgical techniques. 

Furthermore, the healthcare industry in emerging economies is developing at a significant rate, owing to rise in demand for enhanced healthcare services, significant investments by government to improve healthcare infrastructure, and development of the medical tourism industry in emerging countries. This is attributed to further support the market growth. 

Furthermore, rise in consumer awareness related to advance technologies in diagnostic and treatment is expected to drive the market growth. Moreover, increase in promotional activities by manufacturers and growth in awareness about the new techniques among the general population are expected to fuel their adoption in the near future. 

Although several factors drive the growth of the market, high cost associated with this procedure hinder to the growth of market. Accessibility to these procedures for population with financial constraints is limited and such high prices create limitations in accessing these techniques majorly in developing and underdeveloped countries. In addition, in emerging countries there is lack of reimbursement policies to avoid coverage for such costly devices, which hampers demand for vertebroplasty and kyphoplasty.

However, emerging economies of Asia-Pacific and LAMEA present lucrative vertebroplasty and kyphoplasty market opportunity for market players. Surge in healthcare solutions, industrial development, and investments from developed countries in Asia-Pacific, along with rise in awareness regarding new treatment approaches and technologies will provide lucrative opportunities for the market during the forecast period.

The outbreak of COVID-19 has disrupted workflows in the healthcare sector globally. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of healthcare. The global vertebroplasty and kyphoplasty industry experienced decline in 2020 due to global economic recession led by COVID-19. In addition, the COVID-19 outbreak disrupted the supply chain across various end-user industries like food & beverage, healthcare, and industrial. However, the market is anticipated to witness recovery in 2021, and show stable growth in the coming future and is expected to improve as governments have started relaxing norms globally for resuming business activities.  

Segmental Overview

The vertebroplasty and kyphoplasty market is segmented on the basis of product, end user, and region. By product, the market is segmented into vertebroplasty and kyphoplasty. On the basis of end user, the market is segmented into hospitals and ambulatory surgical centers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By Product: 

Based on product, the market is segmented into vertebroplasty and kyphoplasty. The kyphoplasty segment dominated the global vertebroplasty and kyphoplasty market share in 2021, and is expected to remain dominant during the forecast period, owing to advantages that kyphoplasty provides over vertebroplasty, such as reduction in back pain, as well as restoration of vertebral body height and a lower rate of cement extravasation. This is mainly done by placing balloons to gently elevate the fractured vertebrae in an attempt to return it to the correct position. 

Vertebroplasty and Kyphoplasty Market

By End User: 

Based on end user, the market is classified into hospitals and ambulatory surgical centers. The hospitals segment held the largest market share in 2021, whereas the ambulatory surgical centers segment is expected to grow at highest CAGR during the forecast period, owing to huge rise in number of outpatient facilities and ambulatory surgical centers and shift of patients to outpatient facilities than hospitals and clinics.

Vertebroplasty and Kyphoplasty Market

By Region: 

The vertebroplasty and kyphoplasty market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major vertebroplasty and kyphoplasty market share in 2021, and is expected to maintain its dominance during the forecast period. This dominance is mainly attributed the strategies adopted by key market players in this region, such as acquisitions, partnerships, product launch and product approvals.

On the other hand, Asia-Pacific is expected to grow at the highest rate during the forecast period. The market growth in this region is attributable to presence of pharmaceutical and medical devices companies in the region as well as growth in the purchasing power of populated countries, such as China and India. Furthermore, the Asia-Pacific region exhibits the largest supply of healthcare products and is the largest pharmaceuticals industry with availability of raw material in abundance, which can be easily accessed by manufacturers. This, in turn, drives the growth of the market. 

Furthermore, cost of minimally invasive surgeries, such as spinal surgeries in India and other emerging countries, such as China and Japan is comparatively less than other developed countries. This leads to shift of patients toward emerging countries for treatment, which contributes toward growth of the market.

Vertebroplasty and Kyphoplasty Market

COMPETITION ANALYSIS

Competitive analysis and profiles of the major players in the vertebroplasty and kyphoplasty, such as BPB Medica – Biopsybell, Johnson & Johnson (DePuy Synthes), Globus Medical Inc., Halma plc. (IZI Medical Products), Joimax GmbH, Medtronic plc, Merit Medical Systems Inc., Seawon Meditech, Stryker Corporation, and Zavation are provided in this report. Some of the other key market players includes Joline and Fuse Medical which provides many kyphoplasty products. Major players have adopted product launch, partnership, acquisition and product approval as key developmental strategies to improve the product portfolio of the vertebroplasty and kyphoplasty market.  

Product Launch  

In January 2020, Merit Medical announced launch of Arcadia Steerable and Straight Balloons for vertebral augmentation to help physicians achieve controlled, precise cavity creation during unipedicular or bipedicular vertebral augmentation procedures. 

Acquisitions 

In October 2022, Halma announced acquisition of IZI Medical Products, a leading designer, manufacturer and distributor of medical devices used across a range of diagnostic and therapeutic procedures. IZI Medical Products offers vertebroplasty and kyphoplasty products such as DURO-JECT Bone Cement Injector Set, Vertefix HV High Viscosity Bone Cement and Kiva VCF Treatment System, which further expands Halma’s product portfolio. 

In December 2020, Medtronic plc announced acquisition of Medicrea International, a pioneer in the transformation of spinal surgery through artificial intelligence (AI), predictive modeling, and patient specific implants. This further expands the spinal treatment and solution product portfolio of Medtronic plc.

Partnership

In May 2021, Joimax and Trang Thi announced the partnership in bringing the Joimax full-endoscopic and minimally invasive spinal surgery technology to the Southern Provinces of Vietnam including Da Nang market. This strategy is further expected to lead to rise in sales of vertebroplasty and kyphoplasty products of Joimax in Vietnam. 

In October 2020, Joimax announced a new partnership with Transmedic Group, a top medical device distributor headquartered in Singapore, which will represent joimax in Singapore, Hong Kong, Philippines and Indonesia and which is expected to further propel the sales of vertebroplasty and kyphoplasty products of joimax in Singapore.

Clinical Trials

In December 2021, Medtronic plc. announced the results of a study published in Osteoporosis International that demonstrate decrease, and in some cases elimination of oral opioids, and decrease in payer costs following balloon kyphoplasty (BKP) or vertebroplasty (VP) procedures in patients suffering from spinal fractures, known as vertebral compression fractures (VCF), which further causes rise in demand for vertebroplasty and kyphoplasty procedures. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the vertebroplasty and kyphoplasty market analysis from 2021 to 2031 to identify the prevailing vertebroplasty and kyphoplasty market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the vertebroplasty and kyphoplasty market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global vertebroplasty and kyphoplasty industry.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global vertebroplasty and kyphoplasty market trends, key players, market segments, application areas, and market growth strategies.

Vertebroplasty and Kyphoplasty Market Report Highlights

Aspects Details
Market Size By 2031 USD 1.3 billion
Growth Rate CAGR of 5.6%
Forecast period 2021 - 2031
Report Pages 183
By Product
  • Kyphoplasty
  • Vertebroplasty
By End User
  • Hospitals
  • Ambulatory Surgical Centers
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Joimax GmbH, Halma plc, Merit Medical Systems Inc., Medtronic plc, Stryker Corporation, BPB MEDICA – BIOPSYBELL, Globus Medical Inc, Seawon Meditech, Johnson and Johnson (DePuy Synthes), Zavation LLC
 
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Kyphoplasty

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market share analysis by country

    • 4.3 Vertebroplasty

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market share analysis by country

  • CHAPTER 5: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Hospitals

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market share analysis by country

    • 5.3 Ambulatory Surgical Centers

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market share analysis by country

  • CHAPTER 6: VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY REGION

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 North America

      • 6.2.1 Key trends and opportunities

      • 6.2.2 North America Market size and forecast, by Product

      • 6.2.3 North America Market size and forecast, by End User

      • 6.2.4 North America Market size and forecast, by country

        • 6.2.4.1 U.S.
          • 6.2.4.1.1 Key market trends, growth factors and opportunities
          • 6.2.4.1.2 Market size and forecast, by Product
          • 6.2.4.1.3 Market size and forecast, by End User
        • 6.2.4.2 Canada
          • 6.2.4.2.1 Key market trends, growth factors and opportunities
          • 6.2.4.2.2 Market size and forecast, by Product
          • 6.2.4.2.3 Market size and forecast, by End User
        • 6.2.4.3 Mexico
          • 6.2.4.3.1 Key market trends, growth factors and opportunities
          • 6.2.4.3.2 Market size and forecast, by Product
          • 6.2.4.3.3 Market size and forecast, by End User
    • 6.3 Europe

      • 6.3.1 Key trends and opportunities

      • 6.3.2 Europe Market size and forecast, by Product

      • 6.3.3 Europe Market size and forecast, by End User

      • 6.3.4 Europe Market size and forecast, by country

        • 6.3.4.1 Germany
          • 6.3.4.1.1 Key market trends, growth factors and opportunities
          • 6.3.4.1.2 Market size and forecast, by Product
          • 6.3.4.1.3 Market size and forecast, by End User
        • 6.3.4.2 France
          • 6.3.4.2.1 Key market trends, growth factors and opportunities
          • 6.3.4.2.2 Market size and forecast, by Product
          • 6.3.4.2.3 Market size and forecast, by End User
        • 6.3.4.3 UK
          • 6.3.4.3.1 Key market trends, growth factors and opportunities
          • 6.3.4.3.2 Market size and forecast, by Product
          • 6.3.4.3.3 Market size and forecast, by End User
        • 6.3.4.4 Italy
          • 6.3.4.4.1 Key market trends, growth factors and opportunities
          • 6.3.4.4.2 Market size and forecast, by Product
          • 6.3.4.4.3 Market size and forecast, by End User
        • 6.3.4.5 Spain
          • 6.3.4.5.1 Key market trends, growth factors and opportunities
          • 6.3.4.5.2 Market size and forecast, by Product
          • 6.3.4.5.3 Market size and forecast, by End User
        • 6.3.4.6 Rest of Europe
          • 6.3.4.6.1 Key market trends, growth factors and opportunities
          • 6.3.4.6.2 Market size and forecast, by Product
          • 6.3.4.6.3 Market size and forecast, by End User
    • 6.4 Asia-Pacific

      • 6.4.1 Key trends and opportunities

      • 6.4.2 Asia-Pacific Market size and forecast, by Product

      • 6.4.3 Asia-Pacific Market size and forecast, by End User

      • 6.4.4 Asia-Pacific Market size and forecast, by country

        • 6.4.4.1 Japan
          • 6.4.4.1.1 Key market trends, growth factors and opportunities
          • 6.4.4.1.2 Market size and forecast, by Product
          • 6.4.4.1.3 Market size and forecast, by End User
        • 6.4.4.2 China
          • 6.4.4.2.1 Key market trends, growth factors and opportunities
          • 6.4.4.2.2 Market size and forecast, by Product
          • 6.4.4.2.3 Market size and forecast, by End User
        • 6.4.4.3 India
          • 6.4.4.3.1 Key market trends, growth factors and opportunities
          • 6.4.4.3.2 Market size and forecast, by Product
          • 6.4.4.3.3 Market size and forecast, by End User
        • 6.4.4.4 Australia
          • 6.4.4.4.1 Key market trends, growth factors and opportunities
          • 6.4.4.4.2 Market size and forecast, by Product
          • 6.4.4.4.3 Market size and forecast, by End User
        • 6.4.4.5 South Korea
          • 6.4.4.5.1 Key market trends, growth factors and opportunities
          • 6.4.4.5.2 Market size and forecast, by Product
          • 6.4.4.5.3 Market size and forecast, by End User
        • 6.4.4.6 Rest of Asia-Pacific
          • 6.4.4.6.1 Key market trends, growth factors and opportunities
          • 6.4.4.6.2 Market size and forecast, by Product
          • 6.4.4.6.3 Market size and forecast, by End User
    • 6.5 LAMEA

      • 6.5.1 Key trends and opportunities

      • 6.5.2 LAMEA Market size and forecast, by Product

      • 6.5.3 LAMEA Market size and forecast, by End User

      • 6.5.4 LAMEA Market size and forecast, by country

        • 6.5.4.1 Brazil
          • 6.5.4.1.1 Key market trends, growth factors and opportunities
          • 6.5.4.1.2 Market size and forecast, by Product
          • 6.5.4.1.3 Market size and forecast, by End User
        • 6.5.4.2 Saudi Arabia
          • 6.5.4.2.1 Key market trends, growth factors and opportunities
          • 6.5.4.2.2 Market size and forecast, by Product
          • 6.5.4.2.3 Market size and forecast, by End User
        • 6.5.4.3 South Africa
          • 6.5.4.3.1 Key market trends, growth factors and opportunities
          • 6.5.4.3.2 Market size and forecast, by Product
          • 6.5.4.3.3 Market size and forecast, by End User
        • 6.5.4.4 Rest of LAMEA
          • 6.5.4.4.1 Key market trends, growth factors and opportunities
          • 6.5.4.4.2 Market size and forecast, by Product
          • 6.5.4.4.3 Market size and forecast, by End User
  • CHAPTER 7: COMPANY LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top winning strategies

    • 7.3. Product Mapping of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Key developments

  • CHAPTER 8: COMPANY PROFILES

    • 8.1 Johnson and Johnson (DePuy Synthes)

      • 8.1.1 Company overview

      • 8.1.2 Company snapshot

      • 8.1.3 Operating business segments

      • 8.1.4 Product portfolio

      • 8.1.5 Business performance

      • 8.1.6 Key strategic moves and developments

    • 8.2 Medtronic plc

      • 8.2.1 Company overview

      • 8.2.2 Company snapshot

      • 8.2.3 Operating business segments

      • 8.2.4 Product portfolio

      • 8.2.5 Business performance

      • 8.2.6 Key strategic moves and developments

    • 8.3 Globus Medical Inc

      • 8.3.1 Company overview

      • 8.3.2 Company snapshot

      • 8.3.3 Operating business segments

      • 8.3.4 Product portfolio

      • 8.3.5 Business performance

      • 8.3.6 Key strategic moves and developments

    • 8.4 Halma plc

      • 8.4.1 Company overview

      • 8.4.2 Company snapshot

      • 8.4.3 Operating business segments

      • 8.4.4 Product portfolio

      • 8.4.5 Business performance

      • 8.4.6 Key strategic moves and developments

    • 8.5 Zavation LLC

      • 8.5.1 Company overview

      • 8.5.2 Company snapshot

      • 8.5.3 Operating business segments

      • 8.5.4 Product portfolio

      • 8.5.5 Business performance

      • 8.5.6 Key strategic moves and developments

    • 8.6 BPB MEDICA – BIOPSYBELL

      • 8.6.1 Company overview

      • 8.6.2 Company snapshot

      • 8.6.3 Operating business segments

      • 8.6.4 Product portfolio

      • 8.6.5 Business performance

      • 8.6.6 Key strategic moves and developments

    • 8.7 Merit Medical Systems Inc.

      • 8.7.1 Company overview

      • 8.7.2 Company snapshot

      • 8.7.3 Operating business segments

      • 8.7.4 Product portfolio

      • 8.7.5 Business performance

      • 8.7.6 Key strategic moves and developments

    • 8.8 Seawon Meditech

      • 8.8.1 Company overview

      • 8.8.2 Company snapshot

      • 8.8.3 Operating business segments

      • 8.8.4 Product portfolio

      • 8.8.5 Business performance

      • 8.8.6 Key strategic moves and developments

    • 8.9 Joimax GmbH

      • 8.9.1 Company overview

      • 8.9.2 Company snapshot

      • 8.9.3 Operating business segments

      • 8.9.4 Product portfolio

      • 8.9.5 Business performance

      • 8.9.6 Key strategic moves and developments

    • 8.10 Stryker Corporation

      • 8.10.1 Company overview

      • 8.10.2 Company snapshot

      • 8.10.3 Operating business segments

      • 8.10.4 Product portfolio

      • 8.10.5 Business performance

      • 8.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 2. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR KYPHOPLASTY, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 3. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR KYPHOPLASTY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 4. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR VERTEBROPLASTY, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 5. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR VERTEBROPLASTY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 6. GLOBAL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 7. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 8. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 9. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 10. VERTEBROPLASTY AND KYPHOPLASTY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 11. VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 12. NORTH AMERICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 13. NORTH AMERICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 14. NORTH AMERICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 15. U.S. VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 16. U.S. VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 17. CANADA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 18. CANADA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 19. MEXICO VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 20. MEXICO VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 21. EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 22. EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 23. EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 24. GERMANY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 25. GERMANY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 26. FRANCE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 27. FRANCE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 28. UK VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 29. UK VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 30. ITALY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 31. ITALY VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 32. SPAIN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 33. SPAIN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 34. REST OF EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 35. REST OF EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 36. ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 37. ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 38. ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 39. JAPAN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 40. JAPAN VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 41. CHINA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 42. CHINA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 43. INDIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 44. INDIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 45. AUSTRALIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 46. AUSTRALIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 47. SOUTH KOREA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 48. SOUTH KOREA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 49. REST OF ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 50. REST OF ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 51. LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 52. LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 53. LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 54. BRAZIL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 55. BRAZIL VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 56. SAUDI ARABIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 57. SAUDI ARABIA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 58. SOUTH AFRICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 59. SOUTH AFRICA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 60. REST OF LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
    TABLE 61. REST OF LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
    TABLE 62.JOHNSON AND JOHNSON (DEPUY SYNTHES): COMPANY SNAPSHOT
    TABLE 63.JOHNSON AND JOHNSON (DEPUY SYNTHES): OPERATING SEGMENTS
    TABLE 64.JOHNSON AND JOHNSON (DEPUY SYNTHES): PRODUCT PORTFOLIO
    TABLE 65.JOHNSON AND JOHNSON (DEPUY SYNTHES): NET SALES
    TABLE 66.JOHNSON AND JOHNSON (DEPUY SYNTHES): KEY STRATERGIES
    TABLE 67.MEDTRONIC PLC: COMPANY SNAPSHOT
    TABLE 68.MEDTRONIC PLC: OPERATING SEGMENTS
    TABLE 69.MEDTRONIC PLC: PRODUCT PORTFOLIO
    TABLE 70.MEDTRONIC PLC: NET SALES
    TABLE 71.MEDTRONIC PLC: KEY STRATERGIES
    TABLE 72.GLOBUS MEDICAL INC: COMPANY SNAPSHOT
    TABLE 73.GLOBUS MEDICAL INC: OPERATING SEGMENTS
    TABLE 74.GLOBUS MEDICAL INC: PRODUCT PORTFOLIO
    TABLE 75.GLOBUS MEDICAL INC: NET SALES
    TABLE 76.GLOBUS MEDICAL INC: KEY STRATERGIES
    TABLE 77.HALMA PLC: COMPANY SNAPSHOT
    TABLE 78.HALMA PLC: OPERATING SEGMENTS
    TABLE 79.HALMA PLC: PRODUCT PORTFOLIO
    TABLE 80.HALMA PLC: NET SALES
    TABLE 81.HALMA PLC: KEY STRATERGIES
    TABLE 82.ZAVATION LLC: COMPANY SNAPSHOT
    TABLE 83.ZAVATION LLC: OPERATING SEGMENTS
    TABLE 84.ZAVATION LLC: PRODUCT PORTFOLIO
    TABLE 85.ZAVATION LLC: NET SALES
    TABLE 86.ZAVATION LLC: KEY STRATERGIES
    TABLE 87.BPB MEDICA – BIOPSYBELL: COMPANY SNAPSHOT
    TABLE 88.BPB MEDICA – BIOPSYBELL: OPERATING SEGMENTS
    TABLE 89.BPB MEDICA – BIOPSYBELL: PRODUCT PORTFOLIO
    TABLE 90.BPB MEDICA – BIOPSYBELL: NET SALES
    TABLE 91.BPB MEDICA – BIOPSYBELL: KEY STRATERGIES
    TABLE 92.MERIT MEDICAL SYSTEMS INC.: COMPANY SNAPSHOT
    TABLE 93.MERIT MEDICAL SYSTEMS INC.: OPERATING SEGMENTS
    TABLE 94.MERIT MEDICAL SYSTEMS INC.: PRODUCT PORTFOLIO
    TABLE 95.MERIT MEDICAL SYSTEMS INC.: NET SALES
    TABLE 96.MERIT MEDICAL SYSTEMS INC.: KEY STRATERGIES
    TABLE 97.SEAWON MEDITECH: COMPANY SNAPSHOT
    TABLE 98.SEAWON MEDITECH: OPERATING SEGMENTS
    TABLE 99.SEAWON MEDITECH: PRODUCT PORTFOLIO
    TABLE 100.SEAWON MEDITECH: NET SALES
    TABLE 101.SEAWON MEDITECH: KEY STRATERGIES
    TABLE 102.JOIMAX GMBH: COMPANY SNAPSHOT
    TABLE 103.JOIMAX GMBH: OPERATING SEGMENTS
    TABLE 104.JOIMAX GMBH: PRODUCT PORTFOLIO
    TABLE 105.JOIMAX GMBH: NET SALES
    TABLE 106.JOIMAX GMBH: KEY STRATERGIES
    TABLE 107.STRYKER CORPORATION: COMPANY SNAPSHOT
    TABLE 108.STRYKER CORPORATION: OPERATING SEGMENTS
    TABLE 109.STRYKER CORPORATION: PRODUCT PORTFOLIO
    TABLE 110.STRYKER CORPORATION: NET SALES
    TABLE 111.STRYKER CORPORATION: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.VERTEBROPLASTY AND KYPHOPLASTY MARKET SEGMENTATION
    FIGURE 2.VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031
    FIGURE 3.VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.VERTEBROPLASTY AND KYPHOPLASTY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.VERTEBROPLASTY AND KYPHOPLASTY MARKET,BY PRODUCT,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF KYPHOPLASTY VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF VERTEBROPLASTY VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031(%)
    FIGURE 15.VERTEBROPLASTY AND KYPHOPLASTY MARKET,BY END USER,2021(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF HOSPITALS VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031(%)
    FIGURE 17.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031(%)
    FIGURE 18.VERTEBROPLASTY AND KYPHOPLASTY MARKET BY REGION,2021
    FIGURE 19.U.S. VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 20.CANADA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 21.MEXICO VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 22.GERMANY VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 23.FRANCE VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 24.UK VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 25.ITALY VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 26.SPAIN VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 27.REST OF EUROPE VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 28.JAPAN VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 29.CHINA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 30.INDIA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 31.AUSTRALIA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 32.SOUTH KOREA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 33.REST OF ASIA-PACIFIC VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 34.BRAZIL VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 35.SAUDI ARABIA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 36.SOUTH AFRICA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 37.REST OF LAMEA VERTEBROPLASTY AND KYPHOPLASTY MARKET,2021-2031($MILLION)
    FIGURE 38. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 41.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 42.COMPETITIVE DASHBOARD
    FIGURE 43.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 44.JOHNSON AND JOHNSON (DEPUY SYNTHES).: NET SALES ($MILLION)
    FIGURE 45.MEDTRONIC PLC.: NET SALES ($MILLION)
    FIGURE 46.GLOBUS MEDICAL INC.: NET SALES ($MILLION)
    FIGURE 47.HALMA PLC.: NET SALES ($MILLION)
    FIGURE 48.ZAVATION LLC.: NET SALES ($MILLION)
    FIGURE 49.BPB MEDICA – BIOPSYBELL.: NET SALES ($MILLION)
    FIGURE 50.MERIT MEDICAL SYSTEMS INC..: NET SALES ($MILLION)
    FIGURE 51.SEAWON MEDITECH.: NET SALES ($MILLION)
    FIGURE 52.JOIMAX GMBH.: NET SALES ($MILLION)
    FIGURE 53.STRYKER CORPORATION.: NET SALES ($MILLION)

 
 

The adoption of vertebroplasty and kyphoplasty witnessed a significant increase over the past few years. This is majorly attributed to rise in adoption of minimally invasive spinal surgeries and increase in technological advancements in spinal surgery sector. In addition, surge in geriatric population, which are more susceptible to spinal conditions, such as osteoporosis, vertebral column fractures, as well as rise in number of spinal stenosis and other spine disorders are expected to drive the market. Also, rise in number of accidental injuries around the globe leading to severe spinal or vertebral column fractures, is expected to propel the growth of vertebroplasty and kyphoplasty market.

In addition, development of advanced and reliable vertebroplasty and kyphoplasty systems by key market players, has led to extensive number of applications of this technique, thus fueling growth of the market. In addition, increase in demand for minimally invasive procedures and better healthcare services are also expected to propel the market growth due to advantages such as less pain and faster recovery with reduced hospital stays.

Similarly, increase in awareness regarding emerging techniques in surgeries and advancements in instruments and equipment associated with surgical procedures are expected to propel the growth of the vertebroplasty and kyphoplasty market in the future. In addition, new launches and product approvals by key market players around the globe boost the market growth.

Conversely, higher costs associated with the procedure hinder the growth of the market. Furthermore, North America dominated the vertebroplasty and kyphoplasty market in terms of revenue in 2021, owing to well-established healthcare infrastructure, presence of key market players, sufficient government

funding, and awareness among people regarding endoscopic spinal surgery. On the other hand, Asia-Pacific is expected to grow at a prominent CAGR during the forecast period, owing to surge in investments by key market players and availability of resources and raw material in this region.
 

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The forecast period for vertebroplasty and kyphoplasty market is 2022 to 2031

A. The total market value of vertebroplasty and kyphoplasty market is $ 757.1 million in 2021.

A. The base year is 2021 in vertebroplasty and kyphoplasty market.

A. The market value of vertebroplasty and kyphoplasty market in 2031 is $1308.13 million

A. Top companies such as, Medtronic plc, Stryker Corporation, DePuy Synthes (Johnson & Johnson), Globus Medical Inc and Merit Medical Systems Inc. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Kyphoplasty is the most influencing segment in vertebroplasty and kyphoplasty market which is attributed to rise in demand for kyphoplasty surgery as it shows significant result than the tradiitonal surgical treatments.

A. The major factor that fuels the growth of the vertebroplasty and kyphoplasty market are increase in incidence of spinal disorders, rise in demand for advanced and effective treatment for vertebral compression fractures, rise in adoption of minimally invasive surgeries and increase in healthcare spending.

A. vertebroplasty and kyphoplasty are the minimally invasive surgeries used to treat the vertebral compression fractures.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Sample
RELATED TAGS

Purchase Full Report of
Vertebroplasty And Kyphoplasty Market

Start reading instantly.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Nov 2023 - Nov 2024)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2023 - Nov 2024)
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2023 - Nov 2024)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2023 - Nov 2024)
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2023 - Nov 2024)
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers